Autoimmune/Thrombophilic Disorders (as RPL Causes)
Autoimmune and thrombophilic disorders are a category of conditions, acquired and inherited, that elevate clotting risk or disrupt immune tolerance in ways that impair implantation, placentation, and early pregnancy maintenance. They are among the identifiable, treatable causes of recurrent pregnancy loss that thorough evaluation can uncover. The category spans two overlapping groups: autoimmune conditions such as antiphospholipid syndrome and autoimmune thyroid disease, and inherited thrombophilias such as Factor V Leiden, the prothrombin G20210A mutation, and protein C or S deficiency.12
Inherited thrombophilias alter coagulation factor activity, increasing the likelihood of clot formation in small vessels including the placental vasculature. Not all carriers experience adverse pregnancy outcomes. Clinical severity depends on mutation type, zygosity, and the presence of other risk factors. Evaluation through targeted testing can identify these conditions before a subsequent pregnancy attempt.2
On the autoimmune side, antiphospholipid syndrome is the most thoroughly characterized immune cause of pregnancy loss. Thyroid autoimmunity contributes as well: antithyroid antibodies are associated with elevated miscarriage rates even when thyroid hormone levels remain within normal reference ranges.1 The role of natural killer cell activity at the implantation site is an area of ongoing clinical investigation.
Identifying which specific condition or combination is present determines the management direction. Anticoagulation support, immune modulation, and thyroid optimization address distinct mechanisms. They are not interchangeable. Treatment follows diagnosis, not loss count.3
These conditions are diagnosable. Women with recurrent pregnancy loss who carry these conditions are not experiencing unexplained loss. RRM approaches recurrent pregnancy loss as a diagnostic problem rather than a diagnosis of exclusion. Related entries: thrombophilia, methylated folate and MTHFR.
Cited in this entry
- ESHRE guideline: recurrent pregnancy loss. https://pmc.ncbi.nlm.nih.gov/articles/PMC6276652/
- Phillippe M. Cell-free fetal DNA, hemorrhage, and the etiology of term and preterm birth: inherited thrombophilia as a unifying mechanism. Am J Perinatol. 2014. https://rrmacademy.org/library/inherited-thrombophilia-recekazxtzeoab1cu/
- Antithrombotic therapy to prevent recurrent pregnancy loss in antiphospholipid syndrome. https://pmc.ncbi.nlm.nih.gov/articles/PMC8252114/
This content is for educational purposes only and does not constitute medical advice. Consult an RRM clinician or healthcare provider for guidance specific to your situation.